Bridge with intravenous antiplatelet therapy during temporary withdrawal of oral agents for surgical procedures: A systematic review

Internal and Emergency Medicine

Volumn 9, Issue 2, 2014, Pages 225-235

  Morici, Nuccia ^a   Moja, Lorenzo ^b,c   Rosato, Valentina ^d   Sacco, Alice ^a   Mafrici, Antonio ^a   Klugmann, Silvio ^a   D'Urbano, Maurizio ^e   La Vecchia, Carlo ^b,d   De Servi, Stefano ^e   Savonitto, Stefano ^f  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e Ospedale Civile   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Heart diseases; Platelet aggregation inhibitors; Stents; Surgical procedures

Indexed keywords

ANTITHROMBOCYTIC AGENT;

CORONARY BLOOD VESSEL; DRUG ELUTING STENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; SURGERY; TIME; TREATMENT WITHDRAWAL;

ADMINISTRATION, ORAL; CORONARY VESSELS; DRUG-ELUTING STENTS; HUMANS; INFUSIONS, INTRAVENOUS; PLATELET AGGREGATION INHIBITORS; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 84894446075     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-013-1041-8     Document Type: Review

References (44)

1. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB III, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR Jr, Smith SC Jr, Spertus JA, Williams SV (2012) 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 60: e44-e164.
2. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 33: 2569-2619.
3. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32: 2999-3054.
4. Ferraris VA, Saha SP, Oestreich JH, Song HK, Rosengart T, Reece TB, Mazer CD, Bridges CR, Despotis GJ, Jointer K, Clough ER (2012) Society of Thoracic Surgeons. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 94: 1761-1781.
5. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364: 1519-1521.
6. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293: 2126-2130.
7. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ (2006) Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113: 2803-2809.
8. van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, Koolen JJ, Brueren BR, Dambrink JH, Hautvast RW, Verheugt FW, ten Berg JM (2009) Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 53: 1399-1409.
9. Brilakis ES, Banerjee S, Berger PB (2007) Perioperative management of patients with coronary stents. J Am Coll Cardiol 49: 2145-2150.
10. Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H (2006) Coronary artery stenting and non-cardiac surgery-a prospective outcome study. Br J Anaesth 96: 686-693.
11. Anwaruddin S, Askari AT, Saudye H, Batizy L, Houghtaling PL, Alamoudi M, Militello M, Muhammad K, Kapadia S, Ellis SG (2009) Characterization of post-operative risk associated with prior drug-eluting stent use. JACC Cardiovasc Interv 2: 542-549.
12. Cruden NL, Harding SA, Flapan AD, Graham C, Wild SH, Slack R, Pell JP, Newby DE, Scottish Coronary Revascularisation Register Steering Committee (2010) Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv 3: 236-242.
13. Berger PB, Kleiman NS, Pencina MJ, Hsieh WH, Steinhubl SR, Jeremias A, Sonel A, Browne K, Barseness G, Cohen DJ, EVENT Investigators (2010) Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv 3: 920-927.
14. To AC, Armstrong G, Zeng I, Webster MWI (2009) Noncardiac surgery and bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv 2: 213-221.
15. Chassot PG, Delabays A, Spahan D (2007) Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 99: 316-328.
16. Lip GY, Chin BS, Blann AD (2002) Cancer prothrombotic state. Lancet Oncol 3: 27-34.
17. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE (2000) Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35: 1288-1295.
18. Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, Melby S, Berger PB (2003) Clinical outcome of patients undergoing non-cardiac surgery in the two months after coronary stenting. J Am Coll Cardiol 42: 234-240.
19. Nuttall GA, Brown MJ, Stombaugh JW, Michon PB, Hathaway MF, Lindeen KC, Hanson AC, Schroeder DR, Oliver WC, Holmes DR, Rihal CS (2008) Time and cardiac risk of surgery following bare-metal stent percutaneous coronary intervention. Anesthesiology 109: 588-595.
20. Rabbitts JA, Nuttall GA, Brown MJ, Hanson AC, Oliver WC, Holmes DR, Rihal CS (2008) Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 109: 596-604.
21. Schouten O, van Domburg RT, Bax JJ, de Jaegere PJ, Dunkelgrun M, Feringa HH, Hoeks SE, Poldermans D (2007) Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 49: 122-124.
22. Sharma AK, Ajani AE, Hamwi SM, Maniar P, Lakhani SV, Waksman R, Lindsay J (2004) Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 63: 141-145.
23. Riddell JW, Chiche L, Plaud B, Hamon M (2007) Coronary stents and noncardiac surgery. Circulation 116: e378-e382.
24. Singla S, Sachdeva R, Uretsky BF (2012) The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention. J Am Coll Cardiol 60: 2005-2016.
25. Rossini R, Bramucci E, Castiglioni B, De Servi S, Lettieri C, Lettino M, Musumeci G, Visconti LO, Piccaluga E, Savonitto S, Trabattoni D, Buffoli F, Angiolillo DJ, Bovenzi F, Cremonesi A, Scherillo M, Guagliumi G, Società Italiana di Cardiologia Invasiva (GISE), Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) (2012) Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation. G Ital Cardiol (Rome) 13: 528-551.
26. Moga C, Guo B, Schopflocher D, Harstall C (2012) Development of a quality appraisal tool for case series studies using a modified Delphi technique. Institute of Health Economics. Alberta Canada. http://www. ihe. ca/. ISBN (online) 978-1-926929-04-0.
27. Dalkey NC. The Delphi method: an experimental study of group opinion prepared for United States Air Force Project RAND. Santa Monica, CA: RAND Corporation (1969) 192. 5. 14. 43/content/dam/rand/pubs/research_memoranda/2005/RM5888. pdf. Accessed 22 June 2009.
28. Jones J, Hunter D (1995) Consensus methods for medical and health services research. BMJ 311: 376-380.
29. Savonitto S, D'Urbano M, Caracciolo M, Barlocco F, Mariani G, Nichelatti M, Klugmann S, De Servi S (2010) Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 104: 285-291.
30. Savonitto S, Caracciolo M, Cattaneo M, DE Servi S (2011) Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. J Thromb Haemost 9: 2133-2142.
31. Marcos EG, Da Fonseca AC, Hofma SH (2011) Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation. Neth Heart J 19: 412-417.
32. Ceppa DP, Welsby IJ, Wang TY, Onaitis MW, Tong BC, Harpole DH, D'Amico TA, Berry MF (2011) Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection. Ann Thorac Surg 92: 1971-1976.
33. Ben Morrison T, Horst BM, Brown MJ, Bell MR, Daniels PR (2012) Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents. Catheter Cardiovasc Interv 79: 575-582.
34. Rassi AN, Blackstone E, Militello MA, Theodos G, Cavender MA, Sun Z, Ellis SG, Cho L (2012) Safety of "bridging" with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery. Am J Cardiol 110: 485-490.
35. D'Urbano M, Barlocco F, Poli A, Fetiveau R, Vandoni P, Savonitto S, De Servi S (2008) Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy. J Cardiovasc Med 9: 737-741.
36. Angiolillo DJ, Firstenberg MS, Price MJ, Tummala PE, Hutyra M, Welsby IJ, Voeltz MD, Chandna H, Ramaiah C, Brtko M, Cannon L, Dyke C, Liu T, Montalescot G, Manoukian SV, Prats J, Topol EJ, BRIDGE Investigators (2012) Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 307: 265-274.
37. Alshawabkeh LI, Prasad A, Lenkovsky F, Makary LF, Kandil ES, Weideman RA, Kelly KC, Rangan BV, Banerjee S, Brilakis ES (2013) Outcomes of a preoperative "bridging" strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration. EuroIntervention 9: 204-211.
38. Xia JG, Qu Y, Shen H, Liu XH (2013) Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction. Coron Artery Dis 24: 522-526.
39. Bridging therapy in patients at high risk for stent thrombosis undergoing surgery. ClinicalTrials. gov Identifier: NCT00653601.
40. Green S, Higgins JPT, Alderson P, Clarke M, Mulrow CD, Oxman AD (2008) Cochrane handbook for systematic reviews of interventions. Wiley, New york.
41. Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM (2013) Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 310: 1462-1472.
42. Brilakis ES, Patel VG, Banerjee S (2013) Medical management after coronary stent implantation: a review. JAMA 310: 189-198.
43. McDonald SB, Renna M, Spitznagel EL, Avidan M, Hogue CW Jr, Moon MR, Barzilai B, Saleem R, McDonald JM, Despotis GJ (2005) Preoperative use of enoxaparin increases the risk of post-operative bleeding and re-exploration in cardiac surgery patients. J Cardiothorac Vasc Anesth 19: 4-10.
44. Ferreiro JL, Ueno M, Angiolillo DJ (2009) Cangrelor: a review on its mechanism of action and clinical development. Expert Rev Cardiovasc Ther 7: 1195-1201.